Vepesid Capsule
Product Images NDC 69238-2811

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Vepesid (NDC 69238-2811). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Vepesid Etoposide Capsules Usp 1)

Chemical structure of Etoposide, the active ingredient in VePesid 50 mg capsules by Amneal Pharmaceuticals NY LLC. The structure shows detailed molecular bonds including rings and functional groups characteristic of Etoposide.*

FDA Label Image

50 mg 20 Ct Carton (Vepesid Etoposide Capsules Usp 2)

VePesid 50 mg (Etoposide Capsules, USP) oral capsules packaging label. The label indicates a package containing 20 unit dose capsules (two blister strips of 10 capsules each) and is labeled Rx only. It shows storage instructions, cautions, manufacturer Eirgen Pharma Ltd (Ireland), and distributor Amneal Pharmaceuticals LLC (NJ).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.